IPO Issue Details
Issue Price / Price Band₹136 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size110 Shares per Lot
Total Issue Size95,70,000 shares (aggregating up to ₹130.15 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryOffer For Sale
Exchange / PlatformNSE & BSE
IPO TypeMainboard
Subscription OpenMon, 03 Jun 2024
Subscription CloseWed, 05 Jun 2024
Anchor AllotmentFri, 31 May 2024
Basis of AllotmentThu, 06 Jun 2024
Initiation of RefundsFri, 07 Jun 2024
Credit of Shares to DematFri, 07 Jun 2024
Listing DateMon, 10 Jun 2024
UPI Mandate Deadline2024-06-05
Application & Investment Details
Retail — Min (1 Lots)₹14,960 — 110 shares
Retail — Max (13 Lots)₹194,480 (13 Lots)
HNI — Min (14 Lots)₹2,09,440 — 1,540 shares
EPS (Pre-IPO)₹4.48
EPS (Post-IPO)₹5.56
P/E Ratio (Pre-IPO)30.37x
P/E Ratio (Post-IPO)24.47x
Pre-IPO Promoter Holding3,71,04,000 shares
Post-IPO Promoter Holding3,71,04,000 shares
About Kronox Lab Sciences Ltd.
Incorporated in 2008, Kronox Lab Sciences Limited is a manufacturer of high-purity speciality fine chemicals for diverse end-user industries. The company's High Purity Specialty Fine Chemicals are used in various applications such as manufacturing APIs, pharmaceutical formulations, scientific research, nutraceuticals, biotech applications, agrochemical formulations, personal care products, metal refineries, and animal health products.The company offers a wide range of over 185 products, including phosphate, sulphate, acetate, chloride, citrate, nitrates, nitrites, carbonate, EDTA derivatives, hydroxide, succinate, gluconate, and others. These products are supplied to customers in India and more than 20 countries worldwide.The company exports its products to countries such as United States, Argentina, Mexico, Australia, Egypt, Spain, Turkey, United Kingdom, Belgium, United Arab Emirates, China, among others.The company has three manufacturing facilities in Vadodara, Gujarat, close to the seaports of Mundra, Kandla, Hazira, and Nhava Sheva. The facilities cover 17,454 sq. m. and have an installed capacity of 7,242 TPA as of December 31, 2023. Unit I/II holds FSSC 22000 (Version 5), ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018 certifications. Additionally, some products manufactured at Unit I have obtained Kosher, Halal, GMP, and GLP certifications.As of December 31, 2023, the company is conducting research and development on 122 products.The company has served over 592 customers in the past three years. By December 31, 2023, 141 customers of the total, placed repeat orders.As of December 31, 2023, the company employees 212 people at various levels.
Objects of the Issue
Kronox Lab Sciences Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
Carry out the Offer for Sale of up to 95,70,000 Equity Shares by the Promoter Selling Shareholders; and
2
Achieve the benefits of listing the Equity Shares on the Stock Exchanges. Further, the Company expects that the proposed listing of the Equity Shares will enhance the visibility and brand image, provide liquidity to its existing Shareholders, and provide a public market for Equity Shares in India.
Shareholding & Lock-in
Pre-IPO Promoter Holding
3,71,04,000 shares
Post-IPO Promoter Holding
3,71,04,000 shares
Lock-in Period (30%)July 6, 2024
Lock-in Period (50%)September 4, 2024